Remote Patient Monitoring and Digital Therapeutics Enhancing the Continuum of Care in Heart Failure: Nonrandomized Pilot Study
2024

Remote Patient Monitoring and Digital Therapeutics for Heart Failure

Sample size: 52 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mavragani Amaryllis, Sharma Abhinav, Dunn Patrick, Marier-Tétrault Emmanuel, Bebawi Emmanuel, Béchard Stéphanie, Brouillard Philippe, Zuchinali Priccila, Remillard Emilie, Carrier Zoé, Jean-Charles Loyda, Nguyen John Nam Kha, Lehoux Pascale, Pomey Marie-Pascale, Ribeiro Paula A B, Tournoux François

Primary Institution: Centre Hospitalier de l’Université de Montréal

Hypothesis

Can a combined remote patient monitoring and digital therapeutics solution improve heart failure management?

Conclusion

The study showed that integrating a digital solution for heart failure management is feasible and may reduce hospitalizations and improve quality of life.

Supporting Evidence

  • Patients using the app had a lower hospitalization rate compared to those who did not.
  • Quality of life improved significantly for patients who were compliant with the app.
  • 47% of patients in the intervention group used the app for more than 80% of the study period.

Takeaway

This study tested a new way to help heart failure patients by using technology to monitor their health and suggest treatments, which seemed to work well.

Methodology

A 3-month pre-post pilot study with heart failure patients using a mobile app for monitoring and digital therapeutics.

Limitations

The study was not powered and lacked a control group, limiting the ability to assess the true impact of the intervention.

Participant Demographics

Patients aged 65 and older with heart failure, mostly NYHA class II, with a mean age of 69.28 years.

Digital Object Identifier (DOI)

10.2196/53444

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication